ZygoFix Completes $2 Million Round and Launches A New Clinical Study in Israel
Funds to be used for unique back pain solution clinical studies. MISGAV, Israel, March 9, 2021 /PRNewswire/ -- ZygoFix, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), a leading Israel- and Singapore-based investment group focused...